New Key Statistics Module, Z-Score and F-Score
OHEL:OPTOMED Key Ratios
| Market Cap € M | 99.35 |
| Enterprise Value € M | 91.37 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.63 |
| Price/Sales | 5.79 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) € M | 14.00 |
| EPS (TTM) € | -0.28 |
| Beneish M-Score | -3.47 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -21.50 |
| EV-to-EBITDA | -47.89 |
| PEG | -- |
| Shares Outstanding M | 19.60 |
| Net Margin (%) | -32.98 |
| Operating Margin % | -33.86 |
| Pre-tax Margin (%) | -33.47 |
| Quick Ratio | 2.67 |
| Current Ratio | 3.16 |
| ROA % (ttm) | -16.17 |
| ROE % (ttm) | -23.26 |
| ROIC % (ttm) | -26.35 |
| Dividend Yield % | -- |
| Altman Z-Score | 6.00 |
OHEL:OPTOMED Number of Guru Trades
OHEL:OPTOMED Volume of Guru Trades
Gurus Latest Trades with OHEL:OPTOMED
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OHEL:OPTOMED is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers